中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Interaction between hepatitis b virus and toll-like receptors: current status and potential therapeutic use for chronic hepatitis b

文献类型:期刊论文

作者Ma, Zhiyong1; Cao, Qian1; Xiong, Yong1; Zhang, Ejuan2; Lu, Mengji3
刊名Vaccines
出版日期2018-03-01
卷号6期号:1页码:14
关键词Hepatitis b virus Toll-like receptors Innate immunity Adaptive immunity Immunotherapy
ISSN号2076-393X
DOI10.3390/vaccines6010006
通讯作者Lu, mengji(mengji.lu@uni-due.de)
英文摘要Immune defense against infection with the hepatitis b virus (hbv) is complex and involves both host innate and adaptive immune systems. it is well accepted that the development of sufficient hbv-specific t cell and b cell responses are required for controlling an hbv infection. however, the contribution of innate immunity to removing hbv has been explored in recent years. toll-like receptors (tlrs) are recognized as the first line of antiviral immunity because they initiate intracellular signaling pathways to induce antiviral mediators such as interferons (ifns) and other cytokines. recent studies show that the activation of tlr-mediated signaling pathways results in a suppression of hbv replication in vitro and in vivo. however, hbv has also evolved strategies to counter tlr responses including the suppression of tlr expression and the blockage of downstream signaling pathways. antiviral treatment in chronic hbv-infected patients leads to an upregulation of tlr expression and the restoration of its innate antiviral functions. thus, tlr activation may serve as an additional immunotherapeutic option for treating chronic hbv infection in combination with antiviral treatment.
WOS关键词INNATE IMMUNE-RESPONSES ; PLASMACYTOID DENDRITIC CELLS ; CHRONIC HBV INFECTION ; ADJUVANT-CONTAINING VACCINE ; NONPARENCHYMAL LIVER-CELLS ; T-CELLS ; SURFACE-ANTIGEN ; CPG-OLIGODEOXYNUCLEOTIDES ; IN-VIVO ; HEPADNAVIRAL INFECTION
WOS研究方向Immunology ; Research & Experimental Medicine
WOS类目Immunology ; Medicine, Research & Experimental
语种英语
WOS记录号WOS:000443917800005
出版者MDPI
URI标识http://www.irgrid.ac.cn/handle/1471x/2373243
专题武汉病毒研究所
通讯作者Lu, Mengji
作者单位1.Wuhan Univ, Dept Infect Dis, Zhongnan Hosp, Wuhan 430071, Hubei, Peoples R China
2.Chinese Acad Sci, Wuhan Inst Virol, Wuhan 430071, Hubei, Peoples R China
3.Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, D-45122 Essen, Germany
推荐引用方式
GB/T 7714
Ma, Zhiyong,Cao, Qian,Xiong, Yong,et al. Interaction between hepatitis b virus and toll-like receptors: current status and potential therapeutic use for chronic hepatitis b[J]. Vaccines,2018,6(1):14.
APA Ma, Zhiyong,Cao, Qian,Xiong, Yong,Zhang, Ejuan,&Lu, Mengji.(2018).Interaction between hepatitis b virus and toll-like receptors: current status and potential therapeutic use for chronic hepatitis b.Vaccines,6(1),14.
MLA Ma, Zhiyong,et al."Interaction between hepatitis b virus and toll-like receptors: current status and potential therapeutic use for chronic hepatitis b".Vaccines 6.1(2018):14.

入库方式: iSwitch采集

来源:武汉病毒研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。